首页> 外文期刊>Progress in Artificial Intelligence >A Screening Test for Early Diagnosis of Microcellular Bronchopulmonary Cancer-Pilot Study
【24h】

A Screening Test for Early Diagnosis of Microcellular Bronchopulmonary Cancer-Pilot Study

机译:微细胞支气管肺癌癌试验研究的早期诊断筛选试验

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: According to WHO, in worldwide cancer mortality statistics, the first place is occupied by bronchopulmonary cancer. This reason has led us to carry out the present pilot study, was with the participation of the Clinics of Carol Davila University of Medicine and Pharmacy Bucharest in order to apply a technique developed earlier by Stefan-van Staden, for early detection of this type of cancer, initiate a personalized diagnosis, and implicitly apply a personalized treatment in order to increase the life expectancy among these patients. In recent years, there has been a tendency to find fast non-invasive screening methods for the early diagnosis of cancer. Therefore, the present pilot study proposed simultaneous detection of tumor markers (NSE and CEA) by different methods: (1) ELISA kits, (2) the method developed earlier by Stefan-van Staden-which used stochastic sensors, and (3) IHC. All selected patients selected by Dr Claudiu-Eduard Nistor, were suspected of microcellular bronchopulmonary cancer. Tumor tissue samples were collected by conventional and minimally invasive surgical techniques. The results obtained for the detection of markers in blood using ELISA, and stochastic methods (based on stochastic sensors) were correlated with the results obtained using anatomopathological and immunohistochemical analysis of the tumor tissues. Experimental: Stochastic sensors have been used to analyze NSE in blood samples and whole tissues. The IHC was performed for analyzing tumor tissue using standard procedures. ELISA has been used as a standard method to determine specific biomarkers in whole blood samples. Results and discussion: A good correlation was found for results obtained using stochastic and ELISA methods, and IHC for blood and tissue analysis. Statistical evaluation of the data showed that the results of whole blood analysis are correlating very good with the analysis of pulmonary tumor tissue. Therefore, the stochastic method can be used for the detection and for the pursuit of therapeutic efficiency. Conclusions: The data obtained, as well as the statistics, showed that the proposed method can be used as a screening method for fast and early detection of microcellular bronchopulmonary, being minim invasive. It can also be used for monitoring the therapeutic efficiency of the prescribed medication.
机译:介绍:根据谁,在全球癌症死亡率统计中,第一名是支气管胆癌占据。这一原因导致我们开展目前的试点研究,是在Carol Davila Medicinence和Pharmace大学的诊所参与Bucharest,以便使用Stefan-Van Staden早期开发的技术,用于早期检测这种类型癌症,发起个性化诊断,并隐含地应用个性化治疗,以增加这些患者的预期寿命。近年来,在早期诊断癌症的早期诊断,已经存在快速无侵入性筛查方法。因此,本试点研究提出了通过不同方法同时检测肿瘤标志物(NSE和CEA):(1)ELISA试剂盒,(2)由Stefan-Van Staden早期开发的方法 - 其中使用随机传感器,(3)IHC 。所有选定的患者由Claudiu-Eduard Nistor博士选择,被怀疑进行微孔支气管肺癌。通过常规和微创手术技术收集肿瘤组织样品。使用ELISA和随机方法(基于随机传感器的血液中标记检测的结果与使用肿瘤组织的解剖病理学和免疫组织化学分析获得的结果相关。实验:随机传感器已用于分析血液样本和整个组织中的NSE。使用标准程序进行IHC用于分析肿瘤组织。 ELISA已被用作确定全血样品中特定生物标志物的标准方法。结果与讨论:发现使用随机和ELISA方法获得的结果,以及IHC进行血液和组织分析的良好相关性。数据的统计评估表明,全血分析的结果对肺肿瘤组织的分析非常良好。因此,随机方法可用于检测和追求治疗效率。结论:获得的数据以及统计数据显示,所提出的方法可以用作快速和早期检测微孔支气管肺肺胆管的筛选方法,是最微小的侵入性。它还可以用于监测规定药物的治疗效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号